Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 08th Nov 2013 09:21

Abcam: Canaccord Genuity moves target price from 396p to 386p and keeps a sell recommendation. N+1 Singer shifts target price from 450p to 445p downgrading to sell.Aberdeen Asset Management: Jefferies lowers target price from 440p to 430p and reiterates a hold recommendation.Anglo American: Goldman Sachs ups target price from 1100p to 1130p, but still recommends selling.Associated British Foods: Canaccord Genuity moves target price from 1663p to 1680p, but still recommends selling.BAE Systems: Investec cuts target price from 485p to 460p and downgrades from buy to hold.Betfair Group: HSBC initiates with a target price of 1245p and an overweight rating.Bovis Homes Group: Jefferies raises target price from 995p to 1022p and keeps a buy recommendation. Panmure Gordon shifts target price from 873p to 875p and maintains a buy recommendation.Cable & Wireless Communications: Alphavalue shifts target price from 55p to 54.8p and downgrades from buy to add. Espirito Santo shifts target price from 60p to 62p and keeps a buy recommendation.Clarkson: JP Morgan increases target price from 1670p to 1990p and maintains a neutral rating.Dairy Crest Group: JP Morgan raises target price from 543p to 583p keeping an overweight rating.easyJet: Investec cuts target price from 1550p to 1500p, while leaving its buy recommendation unaltered.GlaxoSmithKline: Jefferies takes target price from 1600p to 1700p and retains a hold recommendation.Glencore Xstrata: Investec initiates with a target price of 307p and a sell recommendation.Halfords Group: N+1 Singer raises target price from 475p to 540p and leaves its buy recommendation unchanged. Citi increases target price from 465p to 545p and maintains a buy recommendation. JP Morgan ups target price from 405p to 440p reiterating an overweight rating.Hikma Pharmaceuticals: Panmure Gordon ups target price from 1300p to 1350p retaining a buy recommendation.Inmarsat: JP Morgan cuts target price from 800p to 780p and reiterates an overweight rating. HSBC reduces target price from 750p to 720p leaving its neutral rating unaltered. Societe Generale cuts target price from 670p to 650p and keeps a sell recommendation.Ladbrokers: HSBC starts with a target price of 260p and a neutral rating.Lancashire Holdings: Deutsche Bank lowers target price from 816p to 807p downgrading to hold.London Mining: JP Morgan reduces target price from 215p to 200p keeping its overweight rating.Lonmin: Investec cuts target price from 280p to 266p and downgrades from reduce to sell.Novae Group: Canaccord Genuity raises target price from 520p to 575p and maintains a buy recommendation.Pennon Group: HSBC moves target price from 760p to 740p, while upgrading to overweight.Randgold Resources: Deutsche Bank raises target price from 5050p to 5200p and stays with its buy recommendation. Investec takes target price from 5018p to 5095p retaining a hold recommendation.Record: JP Morgan lowers target price from 45p to 40p, while staying with its overweight rating.Reed Elsevier: Credit Suisse raises target price from 620p to 815p, while staying with its neutral rating.Rightmove: Deutsche Bank increases target price from 2450p to 2650p maintaining a hold recommendation.Schroders: JP Morgan raises target price from 2624p to 2791p leaving its overweight rating. Credit Suisse takes target price from 2350p to 2550p and keeps a neutral rating.Shanks Group: Jefferies moves target price from 110p to 121p and reiterates a hold recommendation. Credit Suisse downgrades from outperform to neutral with a target price of 110p.Tate & Lyle: Societe Generale revises target price from 865p to 900p and stays with its buy recommendation.Waterlogic: Liberum Capital lowers target price from 120p to 110p retaining its hold recommendation. N+1 Singer reduces target price from 235p to 136p, while leaving its buy recommendation unchanged.Weir Group: Berenberg shifts target price from 2680p to 2675p keeping a buy recommendation. Espirito Santo initiates with a target price of 2600p and a buy recommendation.William Hill: HSBC initiates with a target price of 385p and an underweight rating.Wincanton: JP Morgan ups target price from 91p to 106p, while staying with its underweight rating.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.